Revenue: As of FY2025 Q4, the actual value is USD 977.2 M.EPS: As of FY2025 Q4, the actual value is USD 0.1.EBIT: As of FY2025 Q4, the actual value is USD 84.4 M.<h3>Fourth Quarter 2025 (Q4-25) Financial Results</h3><h4>Segment Revenue</h4><ul><li>Bruker Scientific Instruments (BSI): $907.7 million, a decrease of 0.4% year-over-year (YoY), with an organic decrease of 5.1%.</li><li>Bruker Energy &amp; Supercon Technologies (BEST): $71.5 million, a decrease of 0.8% YoY, with an organic decrease of 5.1%.</li></ul><h4>Operational Metrics</h4><ul><li>GAAP Operating Income: $76.3 million, compared to $72.1 million in Q4-24.</li><li>Non-GAAP Operating Income: $153.5 million, compared to $177.5 million in Q4-24.</li><li>Non-GAAP Operating Margin: 15.7%, compared to 18.1% in Q4-24.</li></ul><h4>Cash Flow</h4><ul><li>Cash Flows from Operating Activities: $229.8 million.</li><li>Non-GAAP Free Cash Flow: $207.2 million.</li></ul><h3>Fiscal Year 2025 (FY25) Financial Results</h3><h4>Segment Revenue</h4><ul><li>Bruker Scientific Instruments (BSI): $3.17 billion, an increase of 2.4% compared to FY24, with organic revenue decreasing by 3.5%.</li><li>Bruker Energy &amp; Supercon Technologies (BEST): $270.9 million, a decrease of 4.3% compared to FY24, with an organic decrease of 5.4%.</li></ul><h4>Operational Metrics</h4><ul><li>GAAP Operating Income: $68.2 million, compared to $253.1 million in FY24, which includes non-cash impairment charges to goodwill and intangible assets totaling $127.2 million and restructuring charges of $77.4 million.</li><li>Non-GAAP Operating Income: $433.1 million, a decrease of 16.4% compared to $518.0 million in FY24.</li><li>Non-GAAP Operating Margin: 12.6%, compared to 15.4% in FY24.</li><li>Cost of Revenue: $1,858.8 million.</li><li>Selling, General and Administrative Expenses: $946.5 million.</li><li>Research and Development Expenses: $395.2 million.</li><li>Goodwill Impairment Charge: $96.5 million.</li><li>Other Charges, net: $71.3 million.</li><li>Interest and Other Expense, net: - $46.2 million.</li><li>Income Tax Provision: $29.3 million.</li><li>Equity in Losses of Unconsolidated Investees, net of tax: - $1.0 million.</li><li>Net Income (Loss) Attributable to Bruker Corporation: - $8.6 million.</li><li>Dividends on Series A Mandatory Convertible Preferred Stock: $13.9 million.</li></ul><h4>Cash Flow</h4><ul><li>Cash Flows from Operating Activities: $134.1 million.</li><li>Non-GAAP Free Cash Flow: $43.3 million.</li></ul><h3>Fiscal Year 2026 (FY26) Financial Outlook</h3><ul><li>Bruker Corporation anticipates FY26 revenues to range between $3.57 and $3.60 billion, reflecting a 4% to 5% year-over-year growth, with organic growth projected at 1% to 2%. The company expects a return to organic revenue growth by the second quarter of 2026, despite an expected organic decline in Q1-26.</li></ul>

Bruker Corp Pref Shares BRKRP 6.375 09/01/2028 | 8-K: FY2025 Q4 Revenue: USD 977.2 M